REGISTRATION OPEN
NOTE: LECTURE FROM 05:00 PM – 06:00 PM
WILL BE REPEATED AT 06:00PM – 07:00 PM
NOTE: LECTURE FROM 05:00 PM – 06:00 PM
WILL BE REPEATED AT 06:00PM – 07:00 PM
PROF. NAJI RIACHI
DR. MUSTAFA SHAKRA
THE FIRST AND ONLY CGRP RECEPTOR ANTAGONIST MODERATOR: NASAL SPRAY FOR ACUTE TREATMENT OF MIGRAINE – WHAT YOU NEED TO KNOW?
PIONEERING PRECISION: THE LONG TERM DATA OF THE FIRST AND ONLY SELF ADMINISTERED ANTI CD20 THERAPY IN MS
CAN THE ONLY INTRAVENOUS ACGRP RAISE TREATMENT EXPECTATIONS IN MIGRAINE?
ACHIEVING VALUABLE OUTCOMES IN GENERALISED MYASTHENIA GRAVIS: A CASE BASED APPROACH
ALS IN FOCUS
EFFECTS OF A NEW MULTISITE ELECTRICAL
STIMULATION DEVICE ON MOTOR SYMPTOMS & PAIN
REGISTRATION OPEN
WELCOME MESSAGE & INTRODUCTION
PROF. NAJI RIACHI
DR. OSAMA ELALAMY
DR. MUSTAFA SHAKRA
DR. MOHAMMED SAIDAM
HIDDEN FEATURES OF MS: A FOCUS ON UNNOTICED DISABILITY
MANAGEMENT OF RADIOLODICALLY ISOLATED SYNDROME
2024 UAE MS DMT GUIDELINES
BTK INHIBITORS IN MULTIPLE SCLEROSIS. A LOST CAUSE?
Q&A SESSION
PREVENTING DISABILITY: THE IMPACT OF EARLY HIGH EFFICACY TREATMENT IN MULTIPLE SCLEROSIS
OPTIMIZING MS TREATMENT JOURNEY
PROF. HANAN IBRAHIM
DR. MOHAMMED EL LAHAWI
DR. EMAN GHAZI
CCAD EXPERIENCE IN DEMENTIA NEURO NUCLEAR IMAGING
DEMENTIA CASE STUDIES IN THE IMMUNOTHERAPY ERA
DEMENTIA BEHAVIOR MANAGEMENT
Q&A SESSION
THE POWER TO SLOW ALZHEIMER’S DISEASE
DR. MOHAMMED ALHATOU
DR. ALI HASSAN
DR. RODY EL NAWAR
FUTURE TARGETS FOR MIGRAINE TREATMENT
BEYOND CGRP
WHEN WOULD WE STOP MIGRAINE PROPHYLAXIS?
HEADACHE ABSTRACTS 2024
UPDATE ON MIGRAINE PATHOPHYSIOLOGY
Q&A SESSION
RAPID MIGRAINE RELIEF IN A SINGLE SPRAY: A NEW APPROACH USING AN INTRANASAL CGRP RECEPTOR ANTAGONIST
MIGRAINE PREVENTION UPDATES
REGISTRATION OPEN
WELCOME MESSAGE & INTRODUCTION
DR. MUSTAFA SHAKRA
DR. ABDULLA AL SALTI
DR. ABUBAKER ALMADANI
PROF. MARKUS WEBER
DR. MOHAMMED AL KUWAITI
UPDATE IN THE TREATMENT OF MYASTHENIA GRAVIS
AUTOIMMUNE INFLAMMATORY NEUROPATHIES
– WHAT’S NEW
TREATMENT OF AMYOTROPHIC LATERAL SCLEROSISIN THE 21ST CENTURY, WHERE DO WE STAND
OVERVIEW OF IMAGING IN NEUROMUSCULAR DISORDERS
Q&A SESSION
ATTR POLYNEUROPATH: HOW CAN WE TRANSFORM CARE FOR OUR PATIENTS
CHALLENGES IN MG TREATMENT:
FROM ACH-ESTERASE TO FCRN INHIBITORS
DR. ABDULWAHAB ROMAN
DR. MOHAMAD HARB
DR. ABDULLA AL KUWAITI
DIAGNOSIS AND TREATMENT OF EPILEPSY COMORBIDITIES
IOT DIGITAL THERAPEUTICS FOR SLEEP & BRAIN HEALTH
DRUG RESISTANCE FOCAL EPILEPSY PRACTICAL APPROACH – TOWARDS CURE
Q&A SESSION
DR. SEBY JOHN
DR. TANMOY MAITI
DR. CALINE EL JADAM
SURGICAL TREATMENT FOR PARKINSON’S DISEASE – PATIENT SELECTION FOR DEEP BRAIN STIMULATION AND FOCUSSED ULTRASOUND
APPROACH TO PHENOMENOLOGY OF
MOVEMENT DISORDERS
Q&A SESSION
Copyright © 4th Abu Dhabi Brain Conference All Rights Reserved | Design and Powered by : MCO